Proteins and Peptides
18 January 2017
Protagonist Therapeutics Initiates Phase 2b Study of Oral Drug Candidate PTG-100 in Ulcerative Colitis18 January 2017
SuliquaTM Approved in the European Union for the Treatment of Adults with Type 2 Diabetes12 January 2017
First patient randomised in a phase II study evaluating safety and efficacy of anakinra in the treatment of acute gout7 January 2017
Okogen Secures Ora® to Conduct Clinical and Regulatory Development of OKG-0301 for Adenoviral Conjunctivitis5 January 2017
Synthetic Biologics’ SYN-004 (ribaxamase) Achieves Primary Endpoint in Phase 2b Trial for C. difficile Infection (CDI)5 January 2017
XTL Biopharmaceuticals’ Preclinical Studies of hCDR1 Demonstrate Therapeutic Potental In the Treatment of Sjögren’s Syndrome5 January 2017
Aeterna Zentaris Announces Top-Line Results of Confirmatory Phase 3 Trial of Macrilen™4 January 2017
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera™ for Treatment of Dry Eye1 January 2017
OPKO Health Provides Update on hGH-CTP Clinical Programs27 December 2016
Shire Announces FDA Approval of Adynovate® [Antihemophilic Factor (Recombinant), Pegylated] for use in Children and Surgical Settings23 December 2016
Protalix BioTherapeutics Announces Last Patient Enrolled in the AIR DNase™ Phase II Clinical Trial for Cystic Fibrosis22 December 2016
AzurRx BioPharma Announces First Three Patients Included in Phase IIa Study with MS1819-SD for Endocrine Pancreatic Insufficiency21 December 2016
Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds21 December 2016
Hansa Medical Discontinues its Phase II Study in Acquired Thrombotic Thrombocytopenic Purpura (TTP)19 December 2016
Antares Pharma Announces the Successful Completion of Teva’s Decentralized Procedure for Teriparatide Injection in EuropeNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports